Malnutrition and associated factors among heart failure patients on follow up at Jimma university specialized hospital, Ethiopia by Hiwot Amare et al.
RESEARCH ARTICLE Open Access
Malnutrition and associated factors among
heart failure patients on follow up at Jimma
university specialized hospital, Ethiopia
Hiwot Amare1*, Leja Hamza1 and Henok Asefa2
Abstract
Background: Malnutrition and cachexia are serious consequences of numerous chronic diseases. Severe heart
failure patients could be related with marked weight loss. Malnutrition is associated with poor prognosis among
heart failure patients. Despite its implication, factors associated with malnutrition among heart failure patients in
Africa and Ethiopia was not addressed. Hence, in this study we tried to determine factors associated with
malnutrition among heart failure patients on follow up at Jimma University specialized hospital, Ethiopia.
Methods: A cross-sectional study was done on 284 randomly selected heart failure patients. The nutritional status
of the patients was assessed based on their serum albumin level (normal value 4–5 mg/dl) and triceps skin fold
thickness. The data was analyzed using SPSS version 20.0. Multivariable logistic regression was used to identify
factors associated with malnutrition among heart failure patients using SPSS 20.0.
Results: Based on serum albumin and triceps skin fold thickness, 77.8 % of patients were malnourished. Mean age
of the patients was 48.3 ± 15.9 years. The commonest cause of heart failure was ischemic heart disease (34.9 %).
Hypertension (36 %) was the commonest co morbid disease. Forty four percent of patients had New York heart
association functional class II heart failure. Serum hemoglobin (AOR = 0.77, 95 % CI: 0.67–0.92) was found to be
significantly associated with nutritional status of heart failure patients. As serum hemoglobin increases by 1gm/dl,
the risk of malnutrition decreased by 15 % (P value = 0.03).
Conclusions: The majority of patients were malnourished. A higher hemoglobin concentration was associated with
reduced odds of being malnourished.
Key words: Malnutrition, Angiotensin converting enzyme inhibitors, Serum hemoglobin, Serum albumin, Heart
failure in Ethiopia
Background
Globally, cardiovascular diseases are the leading cause of
death. In 2012, it had caused an estimated 17.5 million
deaths, which accounted 31 % of all global deaths. With
some variation in epidemiology due to the factors associ-
ated with life style, behavioral risk factors, genetic and
racial differences; there is a rise in the burden of cardio-
vascular diseases in low and middle income countries.
Over three quarters of cardiovascular deaths take place
in low- and middle-income countries such as Asia and
Sub-Saharan Africa [1].
A systematic review performed on heart failure and
diabetes in Sub-Saharan Africa, showed that heart
failure accounts for over 30 % of hospital admission
in specialized cardiovascular units and 3–7 % in gen-
eral internal medicine [2]. There are no published
data showing the national prevalence of heart failure
from Africa and Ethiopia.
Cachexia and malnutrition are serious complication
of numerous malignant and non malignant diseases
like chronic obstructive lung disease chronic kidney
disease and severe heart failure. Malnutrition in heart
failure is associated with loss of muscles, fat and bone
mass. Its causes can be due to decreased intake, in-
creased loss of nutrients, increased metabolic rate and
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cytokine dysfunction involving tumor necrosis factor-
alpha (TNF-α), cortisol, epinephrine, renin as well as al-
dosterone. Drugs used in treatment of heart failure such
as angiotensin converting enzyme inhibitors can prevent
malnutrition and sarcopenia in heart failure [3–12].
The assessment of malnutrition in heart failure
might be done by anthropometric and biochemical
tests. Numerous studies had used BMI, mid upper
arm circumference (MUAC), calf circumference and
triceps skin fold thickness [13]. A study from Spain
that assessed the usefulness of body mass index to
characterize the nutritional status in patients with
heart failure concluded that BMI does not indicate true
nutritional status in HF. Among nutritional indicators,
triceps skin fold is a well standardized method of
assessment of malnutrition for age and sex in heart
failure [14].
Serum albumin is one of the biochemical tests to as-
sess nutritional status in heart failure used in numerous
studies. Serum albumin is used in assessment of protein
malnutrition without calorie malnutrition in which
serum albumin becomes low without affection of an-
thropometric measurements [13]. Using serum albumin
has its own limitations such as its variation with several
non nutritional factors such as status of hydration (states
of over hydration lead to overestimation and dehydra-
tion leads to underestimation of serum albumin). Albu-
min is also a negative acute phase reactant therefore;
states of inflammation, infection and malignancies can
also decrease its serum level [15, 16].
Malnutrition was found to be associated with worsen-
ing of symptoms and poor prognosis. Multiple European
studies showed malnourished heart failure patients are
weaker and fatigue earlier [11, 17] and a BMI of 27–29
was found to be ideal in patients with heart failure, with
mortality increasing either side of this range [18, 19].
Heart failure with hypoalbuminemia, as indicator of
malnutrition, was found to be associated with higher
New York heart association (NYHA) functional class, el-
evated serum blood urea nitrogen and C-reactive pro-
tein. It is also linked with lower serum hemoglobin,
sodium and cholesterol [20, 21]. Vitamin and mineral
deficiencies could further increase mortality in these
malnourished patients [22]. Studies done by European
and American researchers also showed that malnutrition
and body wasting were also associated with wasting of
the left ventricle [23].
There are hardly any studies done on malnutrition in
heart failure in Africa and to our knowledge there are
no studies which assessed both prevalence of malnutri-
tion and associated factors among heart failure patients
in Africa and Ethiopia. Hence, this study was conducted
to assess determinant factors affecting malnutrition
among heart failure patients.
Methods and patients
Settings
The study was done on heart failure patients that were
on follow up at Jimma University specialized hospital
(JUSH) located in Jimma town south west Ethiopia. The
hospital serves as a teaching and referral hospital with a
catchment of 15 million people. Heart failure patients
are followed at a weekly cardiac clinic.
Design and data collection
A hospital based cross sectional study was conducted
from November 2013 to June 2014. The list of pa-
tients who were on follow up during the study period
was obtained from the cardiac clinic and using a sim-
ple random sampling technique a sample of 310 pa-
tients who fulfill the inclusion criterion were selected
to be included in the study. Edematous patients and
those who didn’t consent for the study were excluded
because edematous state can lead to over estimation
of serum albumin [15, 16]. The required sample size
was calculated using a single population proportion for-
mula, assuming the prevalence of malnutrition among
heart failure patients to be 50 % to obtain maximum sam-
ple size since this prevalence is unknown. After applying
finite population correction the required sample size to
conduct this study was 310 patients. Ethical clearance was
obtained from the Ethical Committee of Jimma University
college public health and medical sciences (Ethics refer-
ence number – RPGC/266/2013). Verbal consent was also
obtained from patients included in the study.
Data was collected by the primary investigator and
trained clinical nurses. Socio demographic information
was collected using a structured questionnaire from pa-
tients by interview. The patients charts were reviewed to
obtain clinical information such as treatment course,
New York functional class, length of follow up, comor-
bidities and cause of heart failure (from echocardiog-
raphy result). Due to the lack of facilities for coronary
angiography which is the golden standard for the diag-
nosis of ischemic heart disease, the diagnosis of ischemic
heart disease was based on clinical parameters that in-
cluded previous history of ischemia/infarction, abnormal
biomarkers, ECG changes of old Myocardial infarction
and echocardiographic findings of wall motion abnor-
malities, systolic dysfunction assessed by depressed ejec-
tion fraction of less than 50 %. Ejection fraction was
calculated with the formulae systolic volume divided by
end diastolic volume. The diagnosis of rheumatic valvu-
lar heart disease was based on echocardiography that is
identified if it showed multi valvular lesions, valvular re-
gurgitation or stenosis with either thickening or valve
retraction. Hypertensive heart disease was diagnosed if
there was left ventricular hypertrophy or depressed ejec-
tion fraction without wall motion abnormality on patients
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diagnosed with hypertension. Family support was de-
fined as monetary support and support during home
activities such as cooking. The New York functional class
was assessed based on the following categorization.
Class I –Patients with cardiac disease but without
resulting limitation of physical activity. Ordinary physical
activity does not cause undue fatigue, palpitations, dys-
pnea, or anginal pain. Class II –Patients with cardiac
disease resulting in slight limitation of physical activity.
They are comfortable at rest. Ordinary physical activity
results in fatigue, palpitation, dyspnea, or anginal pain.
Class III - Patients with cardiac disease resulting in
marked limitation of physical activity. They are comfort-
able at rest. Less than ordinary activity causes fatigue, pal-
pitation, dyspnea, or anginal pain. Class IV - Patients
with cardiac disease resulting in inability to carry on
any physical activity without discomfort. Symptoms of
heart failure or the anginal syndrome may be present
even at rest. If any physical activity is undertaken, dis-
comfort is increased [24].
Anthropometric measurements such as weight and
height and triceps skin fold thickness were measured.
Weight was measured by a standing weight scale and
height was measured with a height scale after daily
calibration before starting data collection. Triceps skin
fold thickness was measured by Lange skin fold cali-
per beta technology by staff trained in anthropomet-
ric/skin fold assessment. Triceps skin fold thickness is
chosen as it is most used in chronic heart failure pa-
tients and is well standardized based on age and sex
[14]. The mean of three measurements of each of the
anthropometric assessments were taken and was re-
ported as the final measurement.
Blood tests for serum albumin, hemoglobin, mean
corpuscular volume; total lymphocyte count and plate-
let count were performed for biochemical assessments
of nutrition for each patient on the same day of inter-
view. A 5 ml blood sample was taken from the cubital
fossa, 2.5 ml was put in an EDTA tube for complete
blood count and 2.5 ml was put in a tube with no anti-
coagulants for serum albumin determination. Serum al-
bumin was determined by HORIBA medical™ ABX
Pentra 400 with use of appropriate human serum con-
trols. Hemoglobin, mean corpuscular volume (normal
value = 79-93 fl) [25] and total lymphocyte count (normal
value = 710–4530 mm2) [25] and platelet count (165–
415 × 103/mm3) [25] were determined by complete
blood count determination by Cysmex KX21 machine
by the appropriate reagent after daily calibration. All
results were expressed to the nearest 0.1 decimal
place. Nutritional status was assessed based on serum
albumin level and triceps skin fold thickness. Accord-
ingly, a patient was considered as malnourished if
serum albumin level was below 4 mg/dl and triceps
skin fold thickness below the 50th percentile for age
and sex [25, 26].
Data analysis
Data were entered, edited, cleaned, coded and analyzed
using SPSS version 20.0 for Windows. First, descriptive
analysis was done. Then bivariate analysis was done to
identify factors associated with nutritional status. Those
variables in the bivariate analysis with P –value < 0.25
were considered as candidates to be included in the multi-
variable logistic regression model. The multivariate logistic
regression was performed by the backward stepwise vari-
able selection method with probability of removal 0.15.
The adequacy of the model was checked by using Hosmer
and Lemeshow goodness-of-fit test.
Results
A total of 284 patients had participated in this study. Ten
patients refused to participate in the study and 16 patients
had incomplete charts, which made the response rate to
be 91.6 %.
Socio-demographic characteristics of patients
Among the patients, 162 (57.0 %) of them were fe-
males. Mean age of the patients was 48.3 ± 15.9 years.
One hundred ninety two patients (67.0 %) were mar-
ried. One hundred seventy one patients (60.2 %) were
illiterate. One hundred twenty five patients (44.0 %)
were unemployed. More than 49 % have no income
and are dependent on their family and for those with
income the median monthly income of the patients
was 100 birr (5 U.S. Dollars) (Table 1).
Clinical profile
The commonest cause of heart failure was ischemic
heart disease (34.9 %). The median length of follow up
for heart failure was 36 months. From the 144 patients
(50.7 %) that had comorbidity with heart failure, the
commonest comorbidity was hypertension seen in 102
patients (70.8 %). One hundred ninety three patients
(64.3 %) had no admission in the past 12 months. Ac-
cording to the NYHA assessment for functional class for
heart failure patients, 123 (43.5 %) patients were catego-
rized to NYHA functional status of Class II.
Ninety one percent of patients were taking more
than one drug at a time; 179 patients (63 %) were on
ACE-inhibitors; 50 patients (17.6 %) were on Spirono-
lactone; 150 patients (51.1 %) were taking beta
blockers (Table 2).
Nutritional assessment
The current mean weight of the heart failure patients in-
cluded was 53.9 ± 11.9 kg. Thirty six patients (12.7 %) re-
ported that they have noticed weight loss in the past
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6 months. Twenty three patients had reported the
amount of weight loss in the interview and six patients
couldn’t specify the amount of weight loss. The rest did
not report any weight loss in the past 6 months. For
those patients who had reported objective weight loss,
the mean weight lost was 4.5 ± 3.7 kg. The current me-
dian body mass index was 19.6 ± 3.7 kg/m2.
With laboratory investigations conducted from blood
samples of patients, 154 patients (54.6 %) had normocytic,
96 patients (34.0 %) had macrocytic mean corpuscular
volumes and 32 patients (11.3 %) had microcytic mean
corpuscular volumes. The mean serum hemoglobin level
was 12.6 ± 2 gm/dl. With total lymphocytic count, 97.5 %
had normal values. Two hundred forty two patients
(85.2 %) had normal platelet count.
Based on serum albumin and triceps skin fold thickness,
221 patients (77.8 %) were malnourished.
Factors associated with malnutrition
Logistic regression model was used to identify factors
associated with malnutrition among heart failure pa-
tients. Serum hemoglobin (AOR = 0.85, 95 % CI:
0.74–0.98) was found to be significantly associated
with the nutritional status of heart failure patients at
5 % significance level. As serum hemoglobin increases
by 1gm/dl, the risk of malnutrition decreased by 15 %
(P value = 0.03) (Table 3).
Discussion
This study revealed younger heart failure patients as
compared to a multicenter European study (mean age =
67 years) [27] and a study from America (mean age =
61.2 years) [22] but in line with systematic reviews done
by Kengne et al. and Sliwa et al. showed African patients
were relatively younger as compared to their counter-
parts in the rest of the world (mean age = 52 years) [2, 28].
The THESUS-HF registry, which recruited African pa-
tients with acute decompensated heart failure, also
showed a mean age of 52 years which is comparable to
our study [29]. The early onset of heart failure in African
population can be explained by the major contribution of
rheumatic heart disease as a cause (second common
Table 1 Socio-demographic characteristics of heart failure
patients, JUSH, Ethiopia, from November 2013 to June 2014
Patient characteristics Number (%)
















Patients with family support 272 95.8
Patients without family support 12 4.2
Table 2 Clinical profile of heart failure patients, JUSH, Ethiopia,
from November 2013 to June 2014
Clinical profile Frequency %
Total (N = 284)
Cause of heart failure
Ischemic heart disease 99 34.9
Rheumatic valvular heart diseases 83 29.2
Hypertensive heart failure 69 24.3
Cardiomyopathy 25 8.8
Others 8 2.8
New York heart association functional class
Class I 10 3.5
Class II 123 43.5
Class III 99 35.0
Class IV 51 18.0
Comorbid illness
No Comorbid illness 140 49.5
Hypertension 102 36
Chronic kidney disease 17 6
Lung diseases 12 4.2
Others 12 4.2
Admission in the past 12 months
Yes 106 37.3
No 178 62.7
Table 3 Variables associated with malnutrition among heart
failure patients, JUSH, Ethiopia, from November 2013 to June
2014
Clinical profile Adjusted OR (95 % confidence interval) P-value
Serum hemoglobin 0.85 0.74–0.98 0.02
-2 Log likelihood = 295.724
Cox & Snell R Square = 0.017
Nagelkerke R Square = 0.026
Hosmer and Lemeshow Test, x2 = 9.5, P = 0.3
The variables included in the multivariable logistic regression were diuretic
use, ACE –I use, cause of heart failure, frequency of admission in the past
1 year, New York heart association functional class, serum hemoglobin level,
total lymphocyte count
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cause of heart failure in this study) and the early onset
and high prevalence hypertension in Africa as compared
to European and American populations [2, 30, 31].
This study identified ischemic heart disease and
rheumatic valvular heart disease to be the two common
causes of heart failure respectively. This is comparable
with studies from the developed countries but unex-
pected when compared to studies from developing
countries and sub-Saharan Africa; that showed rheum-
atic valvular heart disease to be the most common eti-
ology of heart failure [2] . This disparity could be due
to a possible demographic transition [32], a rise in the
prevalence of type 2 diabetes mellitus in Africa and
Ethiopia [33] and high prevalence of hypertension in
this study population. The unavailability of golden
standard methods of diagnosis of ischemic heart disease
in our set up can lead to over diagnosis.
Hypertension was the commonest co morbid disease
(36 %) in this study, which is in line with a study done
in American by Nicol et al., which showed prevalence
of hypertension to be 44 % [34]. The lower prevalence
of hypertension in our study could be explained by the
younger patients seen in this study as compared to the
study by Nicol et al. (62.8 years) as old age is associ-
ated with higher prevalence of hypertension [25]. Our
result is also in line with other studies from sub-
Saharan Africa, which reviewed data on heart failure
and diabetes, identified hypertension to be the com-
monest comorbidity [2].
Based on serum albumin and triceps skin fold thick-
ness, we have observed a high rate (77.8 %) of malnu-
trition. This finding is higher than a study done in
United Kingdom by Anker et al. and United States by
Mancini et al., which showed prevalence of cardiac
cachexia to be 16 % (assessed by weight loss of >7.5 %
in the past 6 months) and 24 % (based on serum albu-
min) among heart failure patients respectively [35, 36].
This disparity could be due to the difference in the
method of assessment of malnutrition between the
two studies or higher prevalence of malnutrition in
the general Ethiopian population as compared to
American population [37, 38]. The prolonged length
of follow up could also make the prevalence of malnu-
trition to be higher due to progression of heart failure.
The treatment of heart failure in this study population
is suboptimal. Though not directly studied, we specu-
late that the suboptimal treatment of heart failure in
our set up could be due to inability of patients to af-
ford the drugs required due to low income (median
monthly income is 5 USD); which could lead to rapid
progression of heart failure and in turn explain the
higher prevalence of malnutrition in our study [11] .
Only taking a subset of heart failure patients with car-
diomyopathy, another American study showed the
prevalence of malnutrition to be about 50 % that may
not be directly comparable with our study which in-
cluded various causes of heart failure which contribute
to higher prevalence of malnutrition [39].
In our study, the odds of malnutrition were higher in
those who had lower serum hemoglobin level, this is in
line with current knowledge [3, 24, 25]. It is well known
that anemia has a strong impact on NYHA functional
class in heart failure [40]. A Canadian study identified
anemia by itself had a strong impact on clinical outcome
of heart failure patients with higher number of anemic
patients fitting to a higher functional class of heart fail-
ure [39]. Moreover, an Iraqi study done to assess hypoal-
buminemia as a predictor of survival in systolic heart
failure also showed that hypoalbuminemia was associ-
ated with a higher functional class of heart failure and
lower serum hemoglobin level [21, 40].
With limitations of recall bias for subjective weight
loss reporting and incomplete patient charts, the cross
sectional study design which has a short coming of iden-
tifying determinant factors and causal relationships
between multiple factors, the absence of a control arm,
the unavailability of invasive investigations to confirm
the cause of heart failure such as coronary angiography
in the our setup; for the further assessment of other
nutritional parameters such as body density measure-
ment by using body plesthmography, assessment of vita-
min and trace elements, assessment of other acute phase
reactants like C reactive protein and pre albumin, assess-
ment for concomitant other organ dysfunctions, and the
inability to control for socio demographic parameter of
the study participants which can affect nutritional status;
serum hemoglobin was found to be associated with the
nutritional status of heart failure patients.
Conclusions
In conclusion, heart failure patients in our setup are
relatively young. The major cause of heart failure was
ischemic heart disease. Hypertension was the common-
est co morbid disease associated with heart failure.
Majority of heart failure patients were malnourished.
Serum hemoglobin was found to be associated with nu-
tritional status of heart failure patients.
We recommend that multicenter and case control
studies with superior nutritional assessment methods
should be done to further elaborate the association of
serum hemoglobin with nutritional status of heart failure
patients in Ethiopian population.
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